CLINICAL_TRIALS
trial_result
· 2026-02-06
Clinical Trial Update: Intratumoral Cisplatin for Resectable NSCLC [Phase 1]
Summary
Phase 1 trial evaluating intratumoral cisplatin in patients with resectable non-small cell lung cancer has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Vermont | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2026-02-06